NCT06999330
TMS in Anxiety-Parkinson's Disease
Enrolling by Invitation
NAAges 40–90InterventionalTreatmentHealthPartners InstituteInvestigator-initiated
~15 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Theta burst stimulation active coilSham coil
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment Rate
Measured over screening
+5 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Bhavani Kashyap, MBBS, PhD · PRINCIPAL_INVESTIGATOR · HealthPartners Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Recruitment Ratescreening
Percentage of participant who enroll and consent based on those contacted. A higher percentage indicates higher feasibility.
- Participation Rate3 weeks
Percentage of participant who start treatment after enrollment. A higher percentage indicates higher feasibility.
- Fidelity2 weeks
Percentage of participant who complete all treatment sessions. A higher percentage indicates higher fidelity.
- Completion Rate2 weeks
Percentage of participant who complete 7 of the 9 treatment visits. A higher percentage indicates higher completion.
- Adverse Events Rate - Safetyup to 12 weeks
Percentage of participant with adverse events. A lower percentage indicates a safer treatment.
- Adverse Events Safetyup to 12 weeks
Frequency of each adverse event. A higher frequency indicates a less safe treatment.